FDA Wants Unapproved Painkillers Taken Off Shelves

Law360, New York (March 31, 2009, 12:00 AM EDT) -- The U.S. Food and Drug Administration on Tuesday warned eight drug manufacturers and distributors that they had 90 days to remove unapproved but widely used prescription narcotic painkillers from pharmacy shelves or face possible enforcement actions.

The letters also gave the companies 60 days to stop producing 14 unapproved painkillers that include high concentrate morphine sulfate oral solutions and immediate release tablets containing morphine sulfate, hydromorphone or oxycodone, according to a statement from the FDA announcing the move.

The FDA did not include oxycodone capsules in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.